Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Irritable Bowel Syndrome

  Free Subscription


01.01.2020

1 ACS Chem Neurosci
1 ACS Infect Dis
1 Acta Paediatr
2 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 BMC Genomics
1 Bosn J Basic Med Sci
1 Curr Opin Gastroenterol
1 Curr Pharm Biotechnol
1 Diagnostics (Basel)
1 Dig Dis
1 EBioMedicine
1 Future Microbiol
1 Gastroenterol Res Pract
2 Gastroenterology
3 Gut
1 J Ethnopharmacol
3 Lancet Gastroenterol Hepatol
1 Medicine (Baltimore)
1 Nat Prod Rep
1 Neurogastroenterol Motil
1 Neuropharmacology
1 Nutrients
1 Parasite Epidemiol Control
1 PLoS One
1 Sci Rep
1 Zhonghua Nei Ke Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    ACS Chem Neurosci

  1. FU P, Gao M, Yung KKL
    Association of intestinal disorders with Parkinson's disease and Alzheimer's disease: A systematic review and meta-analysis.
    ACS Chem Neurosci. 2019 Dec 26. doi: 10.1021/acschemneuro.9b00607.
    PubMed     Text format     Abstract available


    ACS Infect Dis

  2. YUAN Y, Wang X, Xu X, Liu Y, et al
    Evaluation of a Dual-Acting Antibacterial Agent, TNP-2092, on Gut Microbiota and Potential Application in the Treatment of Gastrointestinal and Liver Disorders.
    ACS Infect Dis. 2019 Dec 18. doi: 10.1021/acsinfecdis.9b00374.
    PubMed     Text format     Abstract available


    Acta Paediatr

  3. GIJSBERS CFM
    Further thoughts on combining Rome III criteria with alarm symptoms for functional gastrointestinal disorders.
    Acta Paediatr. 2019;108:377.
    PubMed     Text format    


    Aliment Pharmacol Ther

  4. REJ A, Buckle RL, Shaw CC, Trott N, et al
    Letter: the gluten-free diet as a bottom-up approach for irritable bowel syndrome.
    Aliment Pharmacol Ther. 2020;51:184-185.
    PubMed     Text format    

  5. TUCK C, Vanner S, Camilleri M, Jing Wang X, et al
    Letter: the gluten-free diet as a bottom-up approach for irritable bowel syndrome. Authors' reply.
    Aliment Pharmacol Ther. 2020;51:185-186.
    PubMed     Text format    


    Am J Gastroenterol

  6. SCARLATA K
    Low FODMAP Diet: What Your Patients Need to Know.
    Am J Gastroenterol. 2019;114:189-191.
    PubMed     Text format    


    BMC Genomics

  7. KIM S, Thapa I, Zhang L, Ali H, et al
    A novel graph theoretical approach for modeling microbiomes and inferring microbial ecological relationships.
    BMC Genomics. 2019;20.
    PubMed     Text format     Abstract available


    Bosn J Basic Med Sci

  8. CHIRA A, Muresan MS, Braicu C, Budisan L, et al
    Serum patterns of mir-23a and mir-181b in irritable bowel syndrome and colorectal cancer - A pilot study.
    Bosn J Basic Med Sci. 2019 Dec 7. doi: 10.17305/bjbms.2019.4392.
    PubMed     Text format     Abstract available


    Curr Opin Gastroenterol

  9. CHUMPITAZI BP
    The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.
    Curr Opin Gastroenterol. 2019 Dec 13. doi: 10.1097/MOG.0000000000000608.
    PubMed     Text format     Abstract available


    Curr Pharm Biotechnol

  10. AZIMI T, Nasser A, Shariati A, Shiadeh SMJ, et al
    The Possible Role of Pathogenic and non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; A Comprehensive Review
    Curr Pharm Biotechnol. 2019 Dec 19. pii: CPB-EPUB-103099.
    PubMed     Text format     Abstract available


    Diagnostics (Basel)

  11. SHARIF H, Devadason D, Abrehart N, Stevenson R, et al
    Imaging Measurement of Whole Gut Transit Time in Paediatric and Adult Functional Gastrointestinal Disorders: A Systematic Review and Narrative Synthesis.
    Diagnostics (Basel). 2019;9.
    PubMed     Text format     Abstract available


    Dig Dis

  12. GRAD S, Dumitrascu DL
    Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions.
    Dig Dis. 2019 Dec 18:1-6. doi: 10.1159/000505287.
    PubMed     Text format     Abstract available


    EBioMedicine

  13. JOHNSEN PH, Hilpusch F, Valle PC, Goll R, et al
    The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
    EBioMedicine. 2019;51:102562.
    PubMed     Text format     Abstract available


    Future Microbiol

  14. LO PRESTI A, Del Chierico F, Altomare A, Zorzi F, et al
    Exploring the genetic diversity of the 16S rRNA gene of Akkermansia muciniphila in IBD and IBS.
    Future Microbiol. 2019 Dec 18. doi: 10.2217/fmb-2019-0175.
    PubMed     Text format     Abstract available


    Gastroenterol Res Pract

  15. WANG Y, Zheng F, Liu S, Luo H, et al
    Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome.
    Gastroenterol Res Pract. 2019;2019:9759138.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. JEFFERY IB, Das A, O'Herlihy E, Coughlan S, et al
    Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Gastroenterology. 2019 Dec 13. pii: S0016-5085(19)41920.
    PubMed     Text format     Abstract available

  17. DELSHAD SD, Almario CV, Chey WD, Spiegel BMR, et al
    Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.
    Gastroenterology. 2019 Dec 18. pii: S0016-5085(19)41941.
    PubMed     Text format     Abstract available


    Gut

  18. BLACK CJ, Burr NE, Camilleri M, Earnest DL, et al
    Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis.
    Gut. 2020;69:74-82.
    PubMed     Text format     Abstract available

  19. EL-SALHY M, Hatlebakk JG, Gilja OH, Brathen Kristoffersen A, et al
    Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    Gut. 2019 Dec 18. pii: gutjnl-2019-319630. doi: 10.1136/gutjnl-2019-319630.
    PubMed     Text format     Abstract available

  20. EDOGAWA S, Edwinson AL, Peters SA, Chikkamenahalli LL, et al
    Serine proteases as luminal mediators of intestinal barrier dysfunction and symptom severity in IBS.
    Gut. 2020;69:62-73.
    PubMed     Text format     Abstract available


    J Ethnopharmacol

  21. KUPELI AKKOL E, Guragac Dereli FT, Tastan H, Sobarzo-Sanchez E, et al
    Effect of Sorbus domestica and its active constituents in an experimental model of colitis rats induced by acetic acid.
    J Ethnopharmacol. 2019 Dec 25. pii: S0378-8741(19)33806.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  22. BLACK CJ, Yuan Y, Selinger CP, Camilleri M, et al
    Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
    Lancet Gastroenterol Hepatol. 2019 Dec 16. pii: S2468-1253(19)30324.
    PubMed     Text format     Abstract available

  23. TORNBLOM H
    Traditional treatments for irritable bowel syndrome: the state of our knowledge.
    Lancet Gastroenterol Hepatol. 2019 Dec 16. pii: S2468-1253(19)30418.
    PubMed     Text format    

  24. SANTUCCI NR, Saps M, van Tilburg MA
    New advances in the treatment of paediatric functional abdominal pain disorders.
    Lancet Gastroenterol Hepatol. 2019 Dec 16. pii: S2468-1253(19)30256.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  25. LEE SH, Cho DY, Joo NS, Kim KN, et al
    Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change.
    Medicine (Baltimore). 2019;98:e18396.
    PubMed     Text format     Abstract available


    Nat Prod Rep

  26. WU XM, Tan RX
    Interaction between gut microbiota and ethnomedicine constituents.
    Nat Prod Rep. 2019;36:788-809.
    PubMed     Text format     Abstract available


    Neurogastroenterol Motil

  27. MUJAGIC Z, Weerts ZZRM, Vork L, Leue C, et al
    Quality of life in irritable bowel syndrome: Authors' reply.
    Neurogastroenterol Motil. 2020;32:e13729.
    PubMed     Text format    


    Neuropharmacology

  28. XU GZ, Xue Y, Wei SQ, Li JH, et al
    Valproate reverses stress-induced somatic hyperalgesia and visceral hypersensitivity by up-regulating spinal 5-HT2C receptor expression in female rats.
    Neuropharmacology. 2019 Dec 26:107926. doi: 10.1016/j.neuropharm.2019.107926.
    PubMed     Text format     Abstract available


    Nutrients

  29. PARISIO C, Lucarini E, Micheli L, Toti A, et al
    Researching New Therapeutic Approaches for Abdominal Visceral Pain Treatment: Preclinical Effects of an Assembled System of Molecules of Vegetal Origin.
    Nutrients. 2019;12.
    PubMed     Text format     Abstract available


    Parasite Epidemiol Control

  30. MELO GB, Malta FM, Maruta CW, Criado PR, et al
    Characterization of subtypes of Blastocystis sp. isolated from patients with urticaria, Sao Paulo, Brazil.
    Parasite Epidemiol Control. 2019;7:e00124.
    PubMed     Text format     Abstract available


    PLoS One

  31. JUNG HK, Tae CH, Moon CM, Kim SE, et al
    Chronic unexplained nausea in adults: Prevalence, impact on quality of life, and underlying organic diseases in a cohort of 5096 subjects comprehensively investigated.
    PLoS One. 2019;14:e0225364.
    PubMed     Text format     Abstract available


    Sci Rep

  32. NOZU T, Miyagishi S, Nozu R, Takakusaki K, et al
    Butyrate inhibits visceral allodynia and colonic hyperpermeability in rat models of irritable bowel syndrome.
    Sci Rep. 2019;9:19603.
    PubMed     Text format     Abstract available


    Zhonghua Nei Ke Za Zhi

  33. ZHANG M, Chen CY, Hu Y, Lyu B, et al
    [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhonghua Nei Ke Za Zhi. 2020;59:40-46.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: